News Shortcuts from other journals
FDA considers curbing use of erythropoietins for patients with cancerBMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.334.7607.1297 (Published 21 June 2007) Cite this as: BMJ 2007;334:1297
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial